Shalby Limited (NSE:SHALBY)
127.49
+1.97 (1.57%)
Nov 12, 2026, 3:30 PM IST
Shalby Revenue
Shalby had revenue of 3.13B INR in the quarter ending September 30, 2026, with 9.72% growth. This brings the company's total for the last twelve months to 12.04B, up 7.27% year-over-year. In the fiscal year ending March 31, 2026, Shalby had annual revenue of 11.41B with 5.01% growth. That makes Shalby the 20,827th largest company in the world by revenue and 1,203rd in India.
Revenue (ttm)
12.04B
Revenue Growth
+7.27%
P/S Ratio
1.14
Revenue / Employee
5.43M
Employees
2,217
Market Cap
13.71B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full Shalby breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 11.41B | 544.74M | 5.01% |
| Mar 31, 2025 | 10.87B | 1.53B | 16.41% |
| Mar 31, 2024 | 9.34B | 1.29B | 16.00% |
| Mar 31, 2023 | 8.05B | 1.06B | 15.16% |
| Mar 31, 2022 | 6.99B | 2.68B | 62.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Paras Healthcare | 18.05B |
| Indraprastha Medical Corporation | 15.55B |
| Artemis Medicare Services | 11.50B |
| Nephrocare Health Services | 11.15B |
| Jeena Sikho Lifecare | 8.51B |
| GPT Healthcare | 5.10B |
| Max India | 2.84B |
| Unihealth Hospitals | 1.32B |
Shalby News
- 8 months ago - Shalby inaugurates oncology department with advanced radiotherapy in Surat hospital - Business Upturn
- 1 year ago - Shalby signs MoU with Bhartiya Skill Development University to launch B.Voc programs in healthcare - Business Upturn
- 1 year ago - Shalby shares drop over 2% as Q1 net profit falls 43% YoY to Rs 8.9 crore, Ebitda down 8% YoY - Business Upturn
- 1 year ago - Shalby shares drop 4% as EBITDA falls 20.1% YoY in Q3 - Business Upturn
- 1 year ago - Shalby shares jump 3% after FDA approval for Duraniom knee replacement device - Business Upturn